NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Further evaluation of a new standard of efficacy for stored platelets.

Author(s): AuBuchon JP, Herschel L, Roger J

Publication: Transfusion, 2005, Vol. 45, Page 1143-50

PubMed ID: 15987360 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of collection method, storage and radiolabel on platelet recovery and survival from blood.

Conclusion of Paper

After 7 days of storage of isolated platelets at 20-24 degrees C, the mean platelet recovery and survival decreased. Generally, manual separation was associated with lower platelet recovery, but longer survival compared to apheresis. When platelets were radiolabelled with indium 111 (In111) or chromium 51 (Cr51) and retransfused, there were no differences in mean platelet recovery or survival rates between the two radiolabels.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of collection method, storage and radiolabel on platelet recovery and survival.

    Summary of Findings:

    Platelets obtained using an apheresis unit that were retransfused on day 1 of storage had a 65.1% recovery rate with an average survival of 7.7 days. After 7 days of storage of platelets at 20-24 degrees C, the mean platelet recovery rate was 56.4%, and the mean survival decreased by 15.7% to 6.5 days. In a second study, manually separated and retransfused platelets showed a mean recovery rate of 59.5% after 1 day and 50.4% after 7 days. Further, the mean survival rate decreased from 8.8 days in platelets retransfused on day 1 to 6.7 days in platelets stored for 7 days. Generally, manual separation was associated with lower platelet recovery, but longer survival compared to apheresis. When platelets were radiolabelled with In111 or Cr51 and retransfused, there were no differences in mean recovery or survival rates between the two radiolabels.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Radioassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration < 1 day
    7 days
    Biospecimen Acquisition Method of fluid acquisition Apheresis
    Venipuncture
    Radioassay Specific Detection method In111
    Cr51
    Biospecimen Aliquots and Components Blood processing method Apheresis
    Manual separation

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...